The importance of clarithromycin dose in the management of H-pylori infection:: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole -: Reply

被引：0
|
作者：
Huang, JQ [1 ]
Hunt, RH [1 ]
机构：
[1] McMaster Univ, Med Ctr, Hamilton, ON, Canada
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 1999年 / 13卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1693 / 1694
页数：2
相关论文
共 50 条
  • [31] Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection
    Murakami, Kazunari
    Okimoto, Tadayoshi
    Kodama, Masaaki
    Sato, Ryugo
    Miyajima, Hajime
    Ono, Masami
    Inoue, Kunimitsu
    Watanabe, Koichiro
    Otsu, Satoshi
    Fujioka, Toshio
    HELICOBACTER, 2006, 11 (05) : 436 - 440
  • [32] Efficacy of the Standard Quadruple Therapy Versus Triple Therapies Containing Proton Pump Inhibitor Plus Amoxicillin and Clarithromycin or Amoxicillin-Clavulanic Acid and Metronidazole for Helicobacter pylori Eradication in Children
    Dehghani, Seyed Mohsen
    Erjaee, Asma
    Imanieh, Mohammad Hadi
    Haghighat, Mahmood
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (08) : 1720 - 1724
  • [33] Efficacy of the Standard Quadruple Therapy Versus Triple Therapies Containing Proton Pump Inhibitor Plus Amoxicillin and Clarithromycin or Amoxicillin-Clavulanic Acid and Metronidazole for Helicobacter pylori Eradication in Children
    Seyed Mohsen Dehghani
    Asma Erjaee
    Mohammad Hadi Imanieh
    Mahmood Haghighat
    Digestive Diseases and Sciences, 2009, 54 : 1720 - 1724
  • [34] A comparison of ranitidine bismuth citrate-clarithromycin (RBC-C) dual therapy vs. omeprazole, clarithromycin, amoxycillin (OCA) triple therapy given for 7 days in the treatment of H-pylori infection
    van Zanten, SJOV
    Chiba, N
    Barkun, AN
    Fallone, CA
    Farley, A
    Cockeram, A
    Dallaire, C
    Simms, L
    Nicholls, B
    GASTROENTEROLOGY, 2001, 120 (05) : A586 - A586
  • [35] Treatment Success With Dual Proton Pump Inhibitor Plus Amoxicillin H. pylori Therapy or PPI, Amoxicillin, Clarithromycin Triple Therapy
    Graham, David Y.
    Javed, Syed U.
    Keihanian, Sara
    Abudayyeh, Suhaib
    Opekun, Antone R.
    GASTROENTEROLOGY, 2010, 138 (05) : S468 - S468
  • [36] Recent use of proton pump inhibitor-based triple therapies for the eradication of H-Pylori:: A broad data review
    Ulmer, HJ
    Beckerling, A
    Gatz, G
    HELICOBACTER, 2003, 8 (02) : 95 - 104
  • [37] High dose vs. standard dose proton pump inhibitor triple therapy for Helicobacter pylori eradication:: A meta-analysis
    Villoria, Albert
    Calvet, Xavier
    Garcia, Pilar
    Gisbert, Javier P.
    Divi, Valenti Puig
    GASTROENTEROLOGY, 2008, 134 (04) : A337 - A337
  • [38] Impact of metronidazole-resistant (M-R) H-pylori strains on PPI-based triple therapies:: A meta-analysis
    Huang, JQ
    Hunt, RH
    GUT, 1999, 45 : A108 - A108
  • [39] Impact of metronidazole-resistant (M-R) H-pylori strains on PPI-based triple therapies:: A meta-analysis
    Huang, JQ
    Hunt, RH
    GASTROENTEROLOGY, 1999, 116 (04) : A191 - A191
  • [40] Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection
    Matsushima, M
    Suzuki, T
    Kurumada, T
    Watanabe, S
    Watanabe, K
    Kobayashi, K
    Deguchi, R
    Masui, A
    Takagi, A
    Shirai, T
    Muraoka, H
    Kobayashi, I
    Mine, T
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (01) : 232 - 236
12345